Novartis doesn't plan on making any large acquisitions, including AstraZeneca, Novartis' chief executive officer said in an interview with Bloomberg News on Monday.
"When you hear rumors about us looking at companies like AstraZeneca, they're not coming from us," Daniel Vasella, Novartis' CEO, told Bloomberg News.
No comments:
Post a Comment